ArticleAnalytical chemistry2025
Field-Portable Technology for Illicit Drug Discrimination via Deep Learning of Hybridized Reflectance/Fluorescence Spectroscopic Fingerprints.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026Review
- The utility of a new point-of-care test for synthetic cannabinoids: a mixed-methods study in people who use synthetic cannabinoids and stakeholders.Harm reduction journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Novel psychoactive substances (NPS) pose one of the greatest challenges across the illicit drug landscape. They can be highly potent, and coupled with rapid changes in structure, tracking and identifying these drugs is difficult and presents users with a "Russian roulette" if used. Benzodiazepines, synthetic opioids, synthetic cannabinoids, and synthetic cathinones account for the majority of NPS-related deaths and harm. Detecting these drugs with existing field-portable technologies is challenging and has hampered the development of community harm reduction services and interventions. Herein, we demonstrate that hybridizing fluorescence and reflectance spectroscopies can accurately identify NPS and provide concentration information with a focus on benzodiazepines and nitazenes. The discrimination is achieved through a deep learning algorithm trained on a library of preprocessed spectral data. We demonstrate the potential for these measurements to be made using a low-cost, portable device that requires minimal user training. Using this device, we demonstrate the discrimination of 11 benzodiazepines from "street" tablets that include bulking agents and other excipients. We show the detection of complex mixtures of multiple drugs, with the key example of nitazene + benzodiazepine (metonitazene + bromazolam), fentanyl + xylazine, and heroin + nitazene (etonitazene) combinations. These samples represent current drug trends and are associated with drug-related deaths. When combined with the implementation of detection technology in a portable device, these data point to the immediate potential to support harm reduction work in community-based settings. Finally, we demonstrate that the approach may be generalized to other drug classes outside NPS discrimination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.